Comparing Alpha Tau Medical (NASDAQ:DRTS) and Autonomix Medical (NASDAQ:AMIX)

Alpha Tau Medical (NASDAQ:DRTS) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Profitability

This table compares Alpha Tau Medical and Autonomix Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-57.29%	-42.39%
Autonomix Medical	N/A	-228.82%	-186.65%

Valuation & Earnings

This table compares Alpha Tau Medical and Autonomix Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63 million	($0.53)	-13.91
Autonomix Medical	N/A	N/A	-$11.41 million	($3.55)	-0.10

Alpha Tau Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Alpha Tau Medical has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -2.48, indicating that its share price is 348% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for Alpha Tau Medical and Autonomix Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1	2	2	0	2.20
Autonomix Medical	1	1	1	0	2.00

Alpha Tau Medical presently has a consensus price target of $8.67, suggesting a potential upside of 17.59%. Autonomix Medical has a consensus price target of $2.00, suggesting a potential upside of 473.07%. Given Autonomix Medical’s higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Alpha Tau Medical.

Summary

Alpha Tau Medical beats Autonomix Medical on 7 of the 11 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.